Position in RGNX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$716,200
+$209,319 QoQ
Shares Held
59,783
-1.2% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 163 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. RGNX ranks #157 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in RGNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $716,200 | 59,783 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $506,881 | 60,487 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $947,880 | 65,825 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $704,681 | 73,024 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $592,351 | 72,150 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $508,758 | 71,155 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $574,099 | 74,269 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,206,612 | 115,025 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,386,754 | 118,526 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,307,986 | 109,539 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,998,391 | 111,331 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,755,195 | 106,634 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,101,388 | 105,122 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,950,490 | 103,146 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,263,055 | 99,782 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,740,262 | 103,680 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,404,668 | 97,355 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,901,702 | 87,427 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,680,876 | 81,984 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,527,442 | 84,147 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,604,541 | 92,781 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,763,319 | 81,012 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $3,246,823 | 71,579 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,090,364 | 75,958 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,189,698 | 86,606 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,970,217 | 91,730 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||